GB964621A - Coumarin salts, the preparation thereof and pharmaceutical compositions thereof - Google Patents
Coumarin salts, the preparation thereof and pharmaceutical compositions thereofInfo
- Publication number
- GB964621A GB964621A GB35329/62A GB3532962A GB964621A GB 964621 A GB964621 A GB 964621A GB 35329/62 A GB35329/62 A GB 35329/62A GB 3532962 A GB3532962 A GB 3532962A GB 964621 A GB964621 A GB 964621A
- Authority
- GB
- United Kingdom
- Prior art keywords
- salts
- preparation
- dialkylaminoethanol
- followed
- coumarin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
- C07D311/44—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3
- C07D311/46—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3 unsubstituted in the carbocyclic ring
- C07D311/48—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3 unsubstituted in the carbocyclic ring with two such benzopyran radicals linked together by a carbon chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
- C07D311/44—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3
- C07D311/46—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3 unsubstituted in the carbocyclic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention comprises dialkylaminoethanol salts of 3-(a -aectonyl) benzyl-4-hydroxycoumarin, and their preparation by direct reaction of the components or by converting an alkali metal salt to the free hydroxy-compound by means of an acid, followed by reaction with a dialkylaminoethanol. The courmarin starting material may be purified by treatment of the alkali-metal salt with a decolorising agent, for example charcoal, followed by precipitation of the free hydroxy-compound by acid. Pharmaceutical preparations: The above salts have anticoagulant activity and may be combined with conventional pharmaceutical carriers in forms suitable for oral, rectal or parenteral administration, e.g. as tablets, granules, lozenges, pills, capsules, suppositories, solutions or suspensions.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE484804 | 1961-09-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB964621A true GB964621A (en) | 1964-07-22 |
Family
ID=3844603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB35329/62A Expired GB964621A (en) | 1961-09-19 | 1962-09-17 | Coumarin salts, the preparation thereof and pharmaceutical compositions thereof |
Country Status (3)
Country | Link |
---|---|
CH (1) | CH411929A (en) |
FR (1) | FR1571M (en) |
GB (1) | GB964621A (en) |
-
1961
- 1961-10-31 FR FR877552A patent/FR1571M/en not_active Expired
-
1962
- 1962-08-31 CH CH1039662A patent/CH411929A/en unknown
- 1962-09-17 GB GB35329/62A patent/GB964621A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
CH411929A (en) | 1966-04-30 |
FR1571M (en) | 1962-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL50849A (en) | 2-phenyl 6-carboxy(or tetrazol-5-yl)3,4-dihydro-quinazolin-4-one(thion)derivatives,process for their preparation and pharmaceutical compositions containing them | |
ES449095A1 (en) | Pyrrolidones and process for their manufacture | |
GB897440A (en) | Improvements in or relating to sulfonamides | |
GB1004468A (en) | Chroman derivatives | |
GB964621A (en) | Coumarin salts, the preparation thereof and pharmaceutical compositions thereof | |
GB1079397A (en) | 1,6-dibromo-1,6-dideoxy dulcitol and pharmaceutical compositions containing it | |
GB828963A (en) | Pharmaceutical compositions containing 2-p-aminobenzenesulphonamido-5-t-butyl-1, 3, 4-thiadiazole | |
JPS51123885A (en) | Process for purifying urokinase | |
IT1057068B (en) | PROCEDURE FOR THE PREPARATION OF GRANULAR MAGNESIUM HYDROXIDE..PARTICULARLY IN ORDER TO OBTAIN MAGNESIUM OXIDE | |
JPS522463A (en) | Structure of glass portion of deformation case | |
ES396186A1 (en) | Procedure for the preparation of a chemical synthesis of oxa-1, oxo-2, diaza-3,8, fenetil-8, spiro (4,5) decane. (Machine-translation by Google Translate, not legally binding) | |
JPS5239642A (en) | A process for preparing protocatechualdehyde | |
OA02703A (en) | Process for the preparation of sulfates of erythromycin derivatives. | |
GB914512A (en) | Novel therapeutic compositions | |
GB931921A (en) | Therapeutic compositions intended for the treatment of any hepatic malfunctionings | |
GB1243837A (en) | Method of production for synthetic wollastonite | |
GB986201A (en) | Improvements in or relating to nitrofurfurylidene-imidazoles | |
GB1000781A (en) | ª-morpholinobutyrophenone and its salts | |
JPS5424842A (en) | Preparation of hydroxybenzaldehydes | |
FR1329570A (en) | Process for preparing alkanoylthio-17alpha-carboxyethyl-17beta-hydroxy-3-oxoandrostenes lactones | |
GB782469A (en) | Anti-t.b. factor | |
GB915038A (en) | Pharmaceutical compositions comprising calcium sulphosuccinate | |
YU149169A (en) | Process for the purification of technical grade o,o-dimethyl-dithio-phosphorylacetic acid derivatives to reduce thetoxicity thereof | |
JPS5253894A (en) | Process for preparing 4-hydroxy-1h-pyrazolo 3,4-d pyrmidine | |
FR1314474A (en) | Process for the preparation of medicinal tablets |